Navigation Links
Smoking can depreciate intellegence

Smoking in old age appears to be linked to intellectual impairment over the age of 64, research has found. A team from the Institute of Psychiatry in London carried out a community survey of an area of England

They studied more than 630 people aged 65 and over. Smoking and drinking habits were recorded at the beginning of the study. The volunteers' intellectual powers were also assessed. After excluding those who had already had evidence of intellectual impairment//, everyone else was followed up a year later to see whether there was any evidence of a decline in intellect.

Of the 415 people who could be retested, one in 14 had suffered significant intellectual decline. The researchers found that smokers were up to five times more likely to have evidence of significant intellectual decline than either non-smokers or former smokers.

This was after taking account of factors known to affect brain function in older people, such as depression and alcohol use. Researcher Martin Prince said: "Our results indicate that persistent cigarette-smoking into late life increases the risk of cognitive impairment."

Smoking contributes to vascular disease and atherosclerosis, conditions which narrow and harden the arteries and impair blood supply to all parts of the body, including the brain. The researchers suggest that this may explain why smoking has an impact on intellect.

The study also found that people who drank moderately before the age of 65 were marginally less likely to have a decline in their mental powers than either heavy or non-alcoholics.


'"/>




Page: 1

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Quit Smoking
8. Smoking Delays Pregnancy
9. Smoking Linked To Low Infant Birth Weight
10. GlaxoSmithKline To Cultivate Non-Smoking Environment
11. Smoking stripes longevity
Post Your Comments:
(Date:7/18/2008)...d Mexican Cuisine are Featured at East LA Meets Na... Services Corporation, LOS ANGELES, July 18 /PRNe...d annual East LA Meets Napa celebration featuring ... wine makers and 20 Los Angeles area Mexican,resta...wine and culinary,enthusiasts who enjoyed great mu...
(Date:7/18/2008)...on the wagon an antidepressant restored brain,s ab... 18 (HealthDay News) -- Giving up your few drinks ...ion, a new study says. , "Our research in an an...nence from alcohol drinking and depression," study...hiatry and pharmacology in the University of North...
(Date:7/18/2008)...t weight loss yields significant health benefits, ...lition -- a group of,experts on overweight and obe...a to reevaluate the way they report on weight loss... news coverage and editorial content that,leads co...ieters if they,lose an enormous amount of weight, ...
(Date:7/18/2008)...Is Not What America Signed Up For, WASHINGTON, Ju...cCain,s,top economic advisor, Phil Gramm, echoed M...were "psychological" by saying Americans are in a ...nation of whiners." While McCain,distanced himself...d as,McCain,s top economic adviser. Now, John McCa...
Breaking Medicine News(10 mins):Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 3Health News:Research Finds Causal Link Between Ending Drinking, Depression 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3
...als have confirmed that the culling operations in ...orted will end on Monday.// Dr B K Wankhade, Regio...hat the operations had begun on March 29 after the...h workers in 82 teams were involved in the operati...
... have confirmed that there has been an outbreak of...er in about 29// villages of Nasik district. Aroun...e have been hospitalized. Malegon was the worst a...18 that were sent to the National Institute of Vir...
...h a new technique for treating the children who su...ease the pain and also prevents deformity. // Int... Hospital outlined his technique for injecting ste... arthritis patients at the Society of Intervention...
...pulation carries the deadly hepatitis virus, a gro...titis B and C is a time bomb waiting to explode un...rol it," said the president of the Pakistan Medica...b, quoting the organisation's annual 2006 report. ...
Other Medicine News:
(Date:7/16/2008)... MOUNTAIN VIEW, Calif., July 16 /PRNewswire-Fi...PP ) announced that the positive results,from a Ph...d,pharmacokinetics of MAP0004 in adult asthmatics ...l Research and Opinion. MAP Pharmaceuticals is,dev...stered therapy, as a,potential treatment for migra...
(Date:7/15/2008)... ATHENS, Ga., July 15 /- Abeome C...nced today a strategic equity,investment by Cato B...Ltd.,its global contract research and development...ll help support continued development of Abeome,s ...y technology vastly improves the development of,mo...
(Date:7/15/2008)... Proceeds to Fund Completion of Phase III Trials ...oma and Metastatic Colorectal Cancer and Phase I/I...asia Studies, BELLEVUE, Wash., July 15 /PRNewswir...tely held company developing Light Infusion Therap...ons, today announced that it,has raised $40.1 mill...
(Date:7/15/2008)... Most Up-to-Date Analysis of the Alzheimer,s Dis...rom Decision Resources, WALTHAM, Mass., July 15 /...d,s leading research and advisory firms for pharma...riad Genetics/Lundbeck,s decision to,discontinue t...to-market,disease-modifying Alzheimer,s disease tr...
Breaking Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2Does the victim affect snake venom composition 3F 588 1Yale scientists make 2 giant steps in advancement of quantum computing 881 1Yale scientists make 2 giant steps in advancement of quantum computing 881 2Yale scientists make 2 giant steps in advancement of quantum computing 881 3C diff infection 4 times more likely to kill patients with inflammatory bowel disease 2158 1HHS Provides Over 24131 Million In Energy Assistance 2156 1HHS Provides Over 24131 Million In Energy Assistance 2156 2
... Demonstrates Significant,Additional Improvement f...2, 2007 /PRNewswire-FirstCall/ --,Indevus Pharmace...e,Company,s Phase II EXPRESS trial for pagoclone i...ented today at the 47th annual,meeting of the New ...y National Institute for Mental Health (NIMH) and ...
... 12, 2007 - Critical,Therapeutics, Inc. (Nasdaq: C...a pivotal Phase III clinical trial of ZYFLO CR(TM)...007 issue of the,Journal of Asthma. ZYFLO CR was a...FDA) on May 30, 2007. Critical Therapeutics,toget... expects to,begin marketing ZYFLO CR in the U.S. i...
Other Medicine Technology:Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5
...cal Table is built to the same rigorous engineerin...al purpose surgical tables, and includes many of t...for enhanced full body imaging. Standard, extremel...ty of accessories. The 1700 Series Table features ...
The schaereraxis 200/300 product range includes 10 different models which have been designed for the varied requirements of different disciplines, whether in the surgical practice, in outpatient surg
... Cmax operating table that combines all the positi...h the radiolucence and precise mobility of an imag...surgical table on the market. The Cmax table is de...res and imaging techniques and has six patented in...
...ability, access, and precise, quiet, vibration-fre...tenuation carbon fiber tabletop accommodates porta...rea is free of cross members, allowing full fluoro...oning. Functional design provides complete access ...
Medicine Products: